BioPhy

Philadelphia, United States

BioPhy's patent pending AI brings predictability and quantifiable risk to drug development

$6.6M raised

Mar 2025

Venture - Series Unknown

Top Investors

Metrodora VenturesAudere CapitalTRCM FundJeffrey Marrazzo

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BioPhy raised?

BioPhy has raised $6.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.

Who are BioPhy's investors?

BioPhy's investors include Metrodora Ventures, Audere Capital, TRCM Fund, Jeffrey Marrazzo.

Where is BioPhy headquartered?

BioPhy is headquartered in Philadelphia, United States.

What does BioPhy do?

BioPhy's patent pending AI brings predictability and quantifiable risk to drug development

What stage is BioPhy at?

BioPhy is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 20, 2025.

MLA

"BioPhy — Funding & Investors." VCBacked, March 20, 2025, https://www.vcbacked.co/company/biophy. Accessed June 19, 2026.

APA

VCBacked. (2025). BioPhy — Funding & Investors. Retrieved June 19, 2026, from https://www.vcbacked.co/company/biophy

Wikipedia (cite web)

{{cite web |title=BioPhy — Funding & Investors |url=https://www.vcbacked.co/company/biophy |website=VCBacked |access-date=June 19, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 20, 2025.